PMC:7253235 / 27892-28197 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"961","span":{"begin":179,"end":187},"obj":"Species"},{"id":"962","span":{"begin":254,"end":262},"obj":"Species"},{"id":"964","span":{"begin":94,"end":112},"obj":"Disease"},{"id":"965","span":{"begin":245,"end":253},"obj":"Disease"}],"attributes":[{"id":"A961","pred":"tao:has_database_id","subj":"961","obj":"Tax:9606"},{"id":"A962","pred":"tao:has_database_id","subj":"962","obj":"Tax:9606"},{"id":"A964","pred":"tao:has_database_id","subj":"964","obj":"MESH:D066126"},{"id":"A965","pred":"tao:has_database_id","subj":"965","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Although some these therapies have potential to provide benefit, there are numerous potential cardiac toxicities and drug-drug interactions that may be harmful to cardio-oncology patients, which is critically relevant since a high percentage of COVID-19 patients have cardiovascular comorbidities [65–68]."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T288","span":{"begin":245,"end":253},"obj":"Disease"}],"attributes":[{"id":"A288","pred":"mondo_id","subj":"T288","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"Although some these therapies have potential to provide benefit, there are numerous potential cardiac toxicities and drug-drug interactions that may be harmful to cardio-oncology patients, which is critically relevant since a high percentage of COVID-19 patients have cardiovascular comorbidities [65–68]."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T198","span":{"begin":224,"end":225},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"Although some these therapies have potential to provide benefit, there are numerous potential cardiac toxicities and drug-drug interactions that may be harmful to cardio-oncology patients, which is critically relevant since a high percentage of COVID-19 patients have cardiovascular comorbidities [65–68]."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T53","span":{"begin":117,"end":121},"obj":"Chemical"},{"id":"T54","span":{"begin":122,"end":126},"obj":"Chemical"}],"attributes":[{"id":"A53","pred":"chebi_id","subj":"T53","obj":"http://purl.obolibrary.org/obo/CHEBI_23888"},{"id":"A54","pred":"chebi_id","subj":"T54","obj":"http://purl.obolibrary.org/obo/CHEBI_23888"}],"text":"Although some these therapies have potential to provide benefit, there are numerous potential cardiac toxicities and drug-drug interactions that may be harmful to cardio-oncology patients, which is critically relevant since a high percentage of COVID-19 patients have cardiovascular comorbidities [65–68]."}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T161","span":{"begin":170,"end":178},"obj":"Phenotype"}],"attributes":[{"id":"A161","pred":"hp_id","subj":"T161","obj":"http://purl.obolibrary.org/obo/HP_0002664"}],"text":"Although some these therapies have potential to provide benefit, there are numerous potential cardiac toxicities and drug-drug interactions that may be harmful to cardio-oncology patients, which is critically relevant since a high percentage of COVID-19 patients have cardiovascular comorbidities [65–68]."}

{"project":"LitCovid-sentences","denotations":[{"id":"T180","span":{"begin":0,"end":305},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Although some these therapies have potential to provide benefit, there are numerous potential cardiac toxicities and drug-drug interactions that may be harmful to cardio-oncology patients, which is critically relevant since a high percentage of COVID-19 patients have cardiovascular comorbidities [65–68]."}

{"project":"2_test","denotations":[{"id":"32462289-27400984-24380957","span":{"begin":298,"end":300},"obj":"27400984"},{"id":"32462289-30400791-24380957","span":{"begin":298,"end":300},"obj":"30400791"},{"id":"32462289-22591294-24380957","span":{"begin":298,"end":300},"obj":"22591294"},{"id":"32462289-10848718-24380957","span":{"begin":298,"end":300},"obj":"10848718"}],"text":"Although some these therapies have potential to provide benefit, there are numerous potential cardiac toxicities and drug-drug interactions that may be harmful to cardio-oncology patients, which is critically relevant since a high percentage of COVID-19 patients have cardiovascular comorbidities [65–68]."}